Journal of Nutrition OpenSOurce Diets- www.ResearchDiets.com

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Nutrition Vol. 74 No. 4 August 1961, pp. 466-472
Copyright © 1961 by American Society for Nutrition
This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lambooy, J. P.
Right arrow Articles by Haley, E. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Lambooy, J. P.
Right arrow Articles by Haley, E. E.

The Biological Activities of 6-Methyl-7-chloro-9-(1'-D-ribityl)isoalloxazine and Dichlororiboflavin1,2,3,

J. P. Lambooy, R. A. Scala and E. E. Haley

Department of Physiology, University of Rochester, School of Medicine and Dentistry, Rochester, New York

6-Methyl-7-chloro-9-(1'-D-ribityl)isoalloxazine has been found to be a potent inhibitor of riboflavin in the nutrition of Lactobacillus casei. It did not, however, inhibit the growth or metabolism of several clinically interesting or important micro-organisms.

This new flavin has been found to stimulate a small growth response in the riboflavin-deficient rat. When administered simultaneously with dietary riboflavin it interferes with the utilization of the latter and is, by virtue of this action, an inhibitor, although a relatively weak one.

The observation that dichlororiboflavin is inert for L. casei has been confirmed and it has been found to be inert in the nutrition of the riboflavin-deficient rat as well.


1 This work was supported in part by grants from the United States Public Health Service. The most recent, grant CY-2940, is from the Cancer Institute.

2 Brief reference was made to a portion of this work at the Symposium on the Antimetabolites, Their Modes of Action and Therapeutic Implication, 10th Annual Meeting, The National Vitamin Foundation, Inc., New York, 1955.

3 6-Methyl-7-chloro-9-(1'-D-ribityl)isoalloxazine has been screened for anticancer activity by the Cancer Chemotherapy National Service Center.

Manuscript received 16 March 1961.





Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]